Abstract
Drug overdose is now the leading cause of injury-related mortality in the USA, but the prognostic utility of cardiac biomarkers is unknown. We investigated whether serum cardiac troponin I (cTnI) was associated with overdose mortality. This prospective observational cohort studied adults with suspected acute drug overdose at two university hospital emergency departments (ED) over 3 years. The endpoint was in-hospital mortality, which was used to determine test characteristics of initial/peak cTnI. There were 437 overdoses analyzed, of whom there were 20 (4.6 %) deaths. Mean initial cTnI was significantly associated with mortality (1.2 vs. 0.06 ng/mL, p < 0.001), and the ROC curve revealed excellent cTnI prediction of mortality (AUC 0.87, CI 0.76–0.98). Test characteristics for initial cTnI (90 % specificity, 99 % negative predictive value) were better than peak cTnI (88.2 % specificity, 99.2 % negative predictive value), and initial cTnI was normal in only one death out of the entire cohort (1/437, CI 0.1–1.4 %). Initial cTnI results were highly associated with drug overdose mortality. Future research should focus on high-risk overdose features to optimize strategies for utilization of cTnI as part of the routine ED evaluation for acute drug overdose.
Similar content being viewed by others
References
Warner M., Chen L. H., Makuc D. M., Anderson R. N., Miniño A. M. (2011). Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief, 81, 1–8.
Warner M., Chen L., Makuc D. (2009). Increase in fatal poisonings involving opioid analgesics in the USA, 1999–2006. In NCHS Data Brief. Hyattsville, MD: National Center for Health Statistics. www.cdc.gov. Accessed 1 July 2014.
Mowry, J. B., Spyker, D. A., Cantilena, L. R., Jr, McMillan, N., & Ford, M. (2014). 2013 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clinical Toxicology (Phila), 52, 1032–1283.
Jang, D. H., Spyres, M. B., Fox, L., & Manini, A. F. (2014). Toxin-induced cardiovascular failure. Emergency Medicine Clinics of North America, 32, 79–102.
Lange, R. A., Cigarroa, R. G., Flores, E. D., McBride, W., Kim, A. S., & Wells, P. J. (1990). Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Annals of Internal Medicine, 112, 897–903.
Manini, A. F., Nelson, L. S., & Hoffman, R. S. (2011). Prognostic utility of serum potassium in chronic digoxin toxicity. American Journal of Cardiovascular Drugs, 11, 173–178.
Andreadou, I., Iliodromitis, E. K., Rassaf, T., Schulz, R., Papapetropoulos, A., & Ferdinandy, P. (2015). The role of gasotransmitters NO, H2S, CO in myocardial ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. British Journal of Pharmacology, 172, 1587–1606.
Manini, A. F., Nelson, L. S., Stimmel, B., & Vlahov, D. (2012). Incidence of adverse cardiovascular events in adults following drug overdose. Academic Emergency Medicine, 19, 843–849.
Vanden Hoek, T. L., Morrison, L. J., Shuster, M., Donnino, M., Sinz, E., & Lavonas, E. J. (2010). Part 12: Cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 122(Suppl 3), S829–S861.
Gaze, D. C., & Collinson, P. O. (2005). Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardiac protection. Expert Opinion on Drug Metabolism and Toxicology, 1, 715–725.
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D. (2012). The writing group on behalf of the joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction: Third universal definition of myocardial infarction. Journal of the American College of Cardiology, 60(12), 1581–1598.
Kelley, W. E., Januzzi, J. L., & Christenson, R. H. (2009). Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clinical Chemistry, 55, 2098–2112.
Tanindi, A., & Cemri, M. (2011). Troponin elevation in conditions other than acute coronary syndromes. Vascular Health and Risk Management, 7, 597–603.
Van Heyningen, C., & Watson, I. D. (2005). Troponin for prediction of cardiovascular collapse in acute colchicine overdose. Emergency Medicine Journal, 22, 599–600.
N.Y. Public Health Law § 2500-d. http://public.leginfo.state.ny.us. Accessed 15 Jan 2015.
Gilbert, E. H., Lowenstein, S. R., Koziol-McLain, J., Barta, D. C., & Steiner, J. (1996). Chart reviews in emergency medicine research: where are the methods? Annals of Emergency Medicine, 27, 305–308.
Manini, A. F., Nelson, L. S., Skolnick, A. H., Slater, W., & Hoffman, R. S. (2010). Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning. Journal of Medical Toxicology, 6, 106–115.
Rockett, I. R., Hobbs, G., De Leo, D., Stack, S., Frost, J. L., & Ducatman, A. M. (2010). Suicide and unintentional poisoning mortality trends in the United States, 1987–2006: Two unrelated phenomena? BMC Public Health, 10, 705.
Acknowledgments
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manini, A.F., Stimmel, B., Hoffman, R.S. et al. Utility of Cardiac Troponin to Predict Drug Overdose Mortality. Cardiovasc Toxicol 16, 355–360 (2016). https://doi.org/10.1007/s12012-015-9345-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-015-9345-8